3701 |
7EJ4 |
IM_B |
chAb25 Full-length |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.6 | Not available or To be published |
3702 |
7EJ4 |
JN_C |
chAb25 Full-length |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.6 | Not available or To be published |
3703 |
7EJ5 |
HL_A |
chAb45 Full-length |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.5 | Not available or To be published |
3704 |
7EJ5 |
IM_B |
chAb45 Full-length |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.5 | Not available or To be published |
3705 |
7EJ5 |
JN_C |
chAb45 Full-length |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3.5 | Not available or To be published |
3706 |
7EJY |
HL_R |
BD-503 Fab |
SARS-CoV-2 spike glycoprotein S1 |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.04 | 10.1038/s41422-021-00554-1 |
3707 |
7EJZ |
HL_R |
BD-503 Fab |
SARS-CoV-2 spike glycoprotein S1 |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
3.63 | 10.1038/s41422-021-00554-1 |
3708 |
7EK0 |
HL_R |
BD-503 Fab |
SARS-CoV-2 spike glycoprotein S1 |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
2.7 | 10.1038/s41422-021-00554-1 |
3709 |
7ELX |
HL_C |
7ELX Fab |
Cytotoxic T-lymphocyte protein 4(CTLA-4) |
Homo sapiens |
XRD |
2.14 | Not available or To be published |
3710 |
7ELX |
hl_c |
7ELX Fab |
Cytotoxic T-lymphocyte protein 4(CTLA-4) |
Homo sapiens |
XRD |
2.14 | Not available or To be published |
3711 |
7ENF |
PO_B |
32C7 Fab |
SARS-CoV-2 S-6P spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
2.76 | 10.1038/s41392-022-00954-8 |
3712 |
7ENG |
HL_B |
32C7 Fab |
SARS-CoV-2 S-6P spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.59 | 10.1038/s41392-022-00954-8 |
3713 |
7EO0 |
HL_3 |
C4 Fv |
Foot-and-mouth disease virus (FMDV) O/TIBET/99 VP3 |
Foot-and-mouth disease virus, Bos taurus |
EM |
3.75 | 10.1128/JVI.00881-21 |
3714 |
7EOW |
B_A |
caplacizumab Nanobody |
von Willebrand factor |
Homo sapiens |
XRD |
1.6 | 10.1016/j.bbrc.2021.06.030 |
3715 |
7EPU |
A_B |
7EPU scFv |
chromodomain helicase/ATPase DNA-binding protein 1-like(CHD1L) |
Homo sapiens |
XRD |
3.5 | 10.1038/s41467-021-24320-4 |
3716 |
7EPX |
HL_A |
GW01 Fab |
SARS-CoV-2 spike glycoprotein ECD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3 | 10.1038/s41421-022-00401-6 |
3717 |
7EPX |
IM_B |
GW01 Fab |
SARS-CoV-2 spike glycoprotein ECD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
3 | 10.1038/s41421-022-00401-6 |
3718 |
7EY0 |
AB_R |
BD-744 Fab |
SARS-CoV-2 Spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.2 | 10.1038/s41422-021-00555-0 |
3719 |
7EY0 |
HL_R |
BD-813 Fab |
SARS-CoV-2 Spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.2 | 10.1038/s41422-021-00555-0 |
3720 |
7EY4 |
HL_R |
BD-667 Fab |
SARS-CoV-2 Spike glycoprotein |
Homo sapiens, Severe acute respiratory syndrome coronavirus 2 |
EM |
3.69 | 10.1038/s41422-021-00555-0 |